Increasing Adoption of DNA Vaccines for Animal Healthcare is Leading the Global DNA Vaccines to Grow at a CAGR of 41.89% by 2026

Boston, MA, June 6, 2018 (Newswire.com) - Browse 20 market data Tables and 30 Figures spread over 162 Pages along with in-depth analysis on “Global DNA vaccines Market by Type (Animal DNA Vaccine, Human DNA Vaccine) by Application (Human Disease, Veterinary Disease) by Technology (Plasmid DNA Vaccines, Plasmid DNA Delivery) by Geography”.

This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive market, by assessing major geographies such as North America, Europe, Asia Pacific, and Rest of World, and is a valuable asset for the existing players, new entrants, and future investors. The study presents a detailed market analysis, with inputs derived from industry professionals across the value chain.

Global DNA vaccines Market is growing at a CAGR of 41.89% during the forecast period 2018-2026.

clive cooper, Corporate Communications

 DNA Vaccine Market scenario

Third generation vaccination is witnessing a surge of investment, DNA vaccines showing great promise in checking the rising prevalence of disease, and increasing adoption of DNA vaccines for animal healthcare are the factors proliferating the growth of the DNA Vaccine market across the globe.

The DNA Vaccine Market report provides data tables and includes charts and graphs for visual analysis.

Request Free Sample Report for DNA Vaccine Market by Technology, End User, Application & Geography: https://www.inkwoodresearch.com/reports/dna-vaccine-market/#request-free-sample

Market Segmentation

On the basis of Type, the DNA Vaccine Market is segmented into:

• Animal DNA vaccine
• Human DNA vaccine

On the basis of technology, the DNA Vaccine Market is segmented into:

• Plasmid DNA vaccines
• Plasmid DNA delivery

On the basis of application, the DNA Vaccine Market is segmented into:

• Human disease
• Veterinary disease

Report Highlights

- The report provides a detailed analysis of the current and future market trends, to identify the investment opportunities
- Market forecasts till 2026, using estimated market values as the base numbers
- Key market trends across the business segments, regions and countries
- Key developments and strategies observed in the market
- Market dynamics such as drivers, restraints, opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2026

Companies Profiled

-        ASTELLAS PHARMA INC.

-        DENDREON CORPORATION (ACQUIRED BY SANPOWER GROUP)

-        ELI LILLY AND COMPANY              

-        EUROGENTEC S.A            

-        GLAXOSMITHKLINE INC.

-        INOVIO PHARMACEUTICALS, INC.            

-        MADISON VACCINES INCORPORATED (MVI)         

-        MERCK & CO.    

-        MERIAL LIMITED (ACQUIRED BY BOEHRINGER INGELHEIM)           

-        NOVARTIS AG

-        SANOFI

-        VGXI     

-        VICAL INCORPORATED   

-        XENETIC BIOSCIENCES INC.         

-        ZOETIS INC

Related Reports

 Bone marrow transplant market - The Global Bone marrow transplant market is anticipated to grow at a CAGR of 5.45% during the forecasting years 2018-2026.

Blood Plasma market – The Global Blood Plasma market is anticipated to grow at a CAGR of 6.62% throughout the forecast years 2018-2026.

Neurorehabilitation device market - The Global Neuro rehabilitation device market is anticipated to grow at a CAGR of 15.24% over the years 2018-2026.

Source: Inkwood Research